アイリーアの世界市場：2033年までの機会と戦略

世界のアイリーア市場は2018年に67億1,100万米ドルと評価され、2023年まで6.00％以上の複合年間成長率（CAGR）で成長しました。

スクリーン時間の増加

スクリーン使用時間の増加がこれまでのアイリーア市場の成長を牽引しました。デジタル機器への依存度が高まるにつれ、デジタル眼精疲労や糖尿病性網膜症、加齢黄斑変性症などの関連疾患の有病率が急上昇しました。患者数の増加により、人々やヘルスケア専門家はタイムリーな治療や定期的な眼科検診の重要性をより強く認識するようになった。こうして、アイリーアはさまざまな網膜疾患の治療法として注目されるようになり、医療関係者はスクリーンでの過度の使用に関連する疾患の治療法として積極的に宣伝しました。例えば、シンガポールを拠点とし、何百もの無料レポートを提供するオンライン・リファレンス・ライブラリーであるDataReportalによると、世界のスクリーンタイムは1日平均6時間40分で、米国は7時間3分です。アメリカの10代の若者は1日8時間を超えることが多く、8歳から12歳の若者は5時間33分を娯楽用スクリーンに費やしています。米国の子どものスクリーン利用時間は、2019年の4時間44分から2021年には5時間33分に増加します。南アフリカは1日9時間24分で、世界平均を2時間44分上回ってトップです。これらの統計は、世界中の消費者行動とデジタル習慣に影響を与えるスクリーン利用動向の重要性を浮き彫りにしています。したがって、スクリーン利用時間の増加はアイリーア市場の成長にプラスの影響を与えます。

目次

第1章 エグゼクティブサマリー

• アイリーア-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

• 一般的な市場の定義
• 概要
• アイリーア市場定義とセグメンテーション
• 製品別の市場セグメンテーション
  • プレフィルドシリンジパッケージ
  • バイアルパッケージ
• 疾患別の市場セグメンテーション
  • 湿潤性加齢黄斑変性
  • 糖尿病網膜症
  • その他の疾患
• 流通チャネル別の市場セグメンテーション
  • 病院
  • 小売薬局
  • その他の流通チャネル

第7章 主要な市場動向

• 治療オプションを強化する新しいアイリーア製剤の発売
• 市場拡大と患者エンゲージメントを促進する戦略的認知キャンペーン
• バイオシミラーの発売が促進 アイリーア市場のアクセスが向上
• 市場プレーヤー間の戦略的パートナーシップとコラボレーション

第8章 アイリーア市場：マクロ経済シナリオ

• COVID-19の影響： アイリーア市場
• ウクライナ戦争の影響： アイリーア市場
• 高インフレの影響： アイリーア市場

第9章 世界の市場規模と成長

• 市場規模
• 市場成長実績、2018-2023
  • 市場促進要因、2018-2023
  • 市場抑制要因、2018-2023
• 市場成長予測、2023-2028、2033F
  • 市場促進要因、2023-2028
  • 市場抑制要因、2023-2028

第10章 世界のアイリーア市場：セグメンテーション

• 世界のアイリーア市場：製品別、実績と予測, 2018-2023, 2028F, 2033F
• 世界のアイリーア市場障害によって、実績と予測, 2018-2023, 2028F, 2033F
• 世界のアイリーア市場：流通チャネル別、実績と予測, 2018-2023, 2028F, 2033F

第11章 アイリーア市場：地域・国別分析

• 世界のアイリーア市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
• 世界のアイリーア市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

• 企業プロファイル
• Regeneron Pharmaceuticals Inc
• Bayer AG
• Biocon Biologics Limited
• Samsung Bioepis Co. Ltd
• Amgen Inc

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

• Sandoz Group AG Completed The Acquisition Of Cimerli, A Ranibizumab Biosimilar, From Coherus Biosciences
• Astellas Pharma Inc Acquired IVERIC Bio Inc
• Coherus BioSciences Inc Acquired Klinge Biopharma GmbH
• AbbVie Inc Acquired Regenxbio Inc

第23章 機会と戦略

• 世界のアイリーア市場2028：新たな機会を提供する国
• 世界のアイリーア市場2028：新たな機会を提供するセグメント
• 世界のアイリーア市場2028：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第24章 アイリーア市場：結論と提言

• 結論
• 提言
  • 製品
  • 場所
  • 価格
  • プロモーション
  • 人々

第25章 付録

Eylea, also known by its generic name aflibercept, is a medication primarily used for the treatment of several serious eye disorders. Developed as an anti-VEGF (vascular endothelial growth factor) injection, eylea is designed to inhibit abnormal blood vessel growth and leakage within the eye, a primary cause of vision impairment in conditions such as wet age-related macular degeneration (wet AMD) and diabetic retinopathy (DR).

The eylea market consists of sales, by entities (organizations, sole traders and partnerships) of eylea products that critical for patients at risk of severe visual impairment or blindness, especially those with progressive retinal disorders that might otherwise have few alternative treatment options.

The global eylea market was valued at $ 6,711.00 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.00%.

Increased Screen Time

During the historic period, increased screen time drove the growth of the eylea market. The prevalence of digital eye strain and associated disorders including diabetic retinopathy and age-related macular degeneration rose sharply as dependence on digital gadgets increased. Due to the increase in cases, people and healthcare professionals were more aware of the importance of timely treatments and routine eye exams. Thus, eylea emerged as a preferred treatment for various retinal disorders and medical practitioners aggressively promoted it as a cure for disorders associated with excessive screen time. For instance, according to DataReportal, a Singapore-based online reference library offering hundreds of free reports, global screen time averages 6 hours 40 minutes daily, with the US at 7 hours 3 minutes. American teens often exceed 8 hours daily, while 8-12-year-olds spend 5 hours and 33 minutes on entertainment screens. Child screen time in the US rose from 4 hours 44 minutes in 2019 to 5 hours 33 minutes in 2021. South Africans lead with 9 hours and 24 minutes daily, surpassing the global average by 2 hours and 44 minutes. These statistics highlight significant screen usage trends impacting consumer behavior and digital habits worldwide. Therefore, increased screen time positively impacted the growth of the eylea market.

Launch Of New Eylea Formulations To Enhance Treatment Options

Major companies in the eylea market are focusing on new product launches to expand the range of treatment options and meet the evolving needs of patients. By introducing formulations with improved dosing schedules, extended-release technologies or new indications, these launches enhance the versatility of eylea, attracting more patients and healthcare providers. These innovations not only help strengthen eylea's market position but also contribute to its continued growth by offering solutions that improve patient compliance and outcomes. For example, in January 2024, Bayer, a Germany-based pharmaceutical and biotechnology company, launched new eylea(TM) 8 mg (aflibercept 8 mg, 114.3 mg/ml solution for injection) for the treatment of two major retinal diseases, neovascular (wet) age-related macular degeneration (nAMD) and visual impairment due to diabetic macular edema (DME). The European Commission has granted marketing authorization in the European Union (EU) for new eylea(TM) 8 mg (aflibercept 8 mg). Eylea 8 mg is an important advancement in retinal care as it provides great and long-lasting control of the disease.

The global eylea market is highly concentrated, with large players operating in the market. The top competitors in the market made up to 100.0% of the total market in 2023.

Eylea Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global eylea market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for eylea? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The eylea market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider eylea market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by disorder and by distribution channel.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the eylea market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by disorder and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for eylea providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Product: Prefilled Syringe Package; Vial Package
• 2) By Disorder: Wet-Age Related Macular Degeneration (AMD); Diabetic Retinopathy; Other Disorders
• 3) By Distribution Channel: Hospitals; Retail Pharmacy; Other Distribution Channel
• Companies Mentioned: Regeneron Pharmaceuticals Inc.; Bayer AG; Biocon Biologics Limited; Samsung Bioepis Co. Ltd.; Amgen Biosimilar Inc.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; eylea indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Eylea - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Eylea Market Definition And Segmentations
• 6.4 Market Segmentation By Product
  • 6.4.1 Prefilled Syringe Package
  • 6.4.2 Vial Package
• 6.5 Market Segmentation By Disorder
  • 6.5.1 Wet-Age Related Macular Degeneration
  • 6.5.2 Diabetic Retinopathy
  • 6.5.3 Other Disorders
• 6.6 Market Segmentation By Distribution Channel
  • 6.6.1 Hospitals
  • 6.6.2 Retail Pharmacy
  • 6.6.3 Other Distribution Channel

7 Major Market Trends

• 7.1 Launch Of New Eylea Formulations To Enhance Treatment Options
• 7.2 Strategic Awareness Campaigns Driving Market Expansion And Patient Engagement
• 7.3 Launch Of Biosimilars Enhancing Eylea Market Accessibility
• 7.4 Strategic Partnerships And Collaborations Among Market players

8 Eylea Market - Macro Economic Scenario

• 8.1 COVID-19 Impact On The Eylea Market
• 8.2 Impact Of The War In Ukraine On The Eylea Market
• 8.3 Impact Of High Inflation On The Eylea Market

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Eylea Market Segmentation

• 10.1 Global Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Eylea Market, Regional and Country Analysis

• 11.1 Global Eylea Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Eylea Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate Tax Structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Asia Pacific Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia Pacific Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia Pacific Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.6 Asia-Pacific Eylea Market: Country Analysis
• 12.7 China Market
• 12.8 Summary
• 12.9 Market Overview
  • 12.9.1 Country Information
  • 12.9.2 Market Information
  • 12.9.3 Background Information
  • 12.9.4 Government Initiatives
  • 12.9.5 Regulations
  • 12.9.6 Regulatory Bodies
  • 12.9.7 Major Associations
  • 12.9.8 Taxes Levied
  • 12.9.9 Corporate Tax Structure
  • 12.9.10 Investments
  • 12.9.11 Major Companies
• 12.10 China Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 China Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.12 China Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Market
• 12.14 India Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 India Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.16 India Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Market
• 12.18 Japan Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Japan Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.20 Japan Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Market
• 12.22 Australia Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Australia Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.24 Australia Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Market
• 12.26 Indonesia Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 Indonesia Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.28 Indonesia Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Market
• 12.30 South Korea Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.31 South Korea Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.32 South Korea Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Investments
  • 13.2.11 Major Companies
• 13.3 Western Europe Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.6 UK Market
• 13.7 UK Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.8 UK Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 Germany Market
• 13.11 Germany Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.12 Germany Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 France Market
• 13.15 France Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.16 France Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 Italy Market
• 13.19 Italy Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.20 Italy Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Spain Market
• 13.23 Spain Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.24 Spain Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Major companies
• 14.3 Eastern Europe Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.6 Russia Market
• 14.7 Russia Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.8 Russia Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Investments
  • 15.2.11 Major Companies
• 15.3 North America Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.6 USA Market
• 15.7 Summary
• 15.8 Market Overview
  • 15.8.1 Country Information
  • 15.8.2 Market Information
  • 15.8.3 Background Information
  • 15.8.4 Government Initiatives
  • 15.8.5 Regulations
  • 15.8.6 Regulatory Bodies
  • 15.8.7 Major Associations
  • 15.8.8 Taxes Levied
  • 15.8.9 Corporate Tax Structure
  • 15.8.10 Investments
  • 15.8.11 Major Companies
• 15.9 USA Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.10 USA Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 USA Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.12 Canada Market
• 15.13 Canada Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.14 Canada Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.15 Canada Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Major Companies
• 16.3 South America Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.6 Brazil Market
• 16.7 Brazil Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.8 Brazil Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Investments
  • 17.2.11 Major Companies
• 17.3 Middle East Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.5 Middle East Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
• 18.2 Market Overview
  • 18.2.1 Region Information
  • 18.2.2 Market Information
  • 18.2.3 Background Information
  • 18.2.4 Government Initiatives
  • 18.2.5 Regulations
  • 18.2.6 Regulatory Bodies
  • 18.2.7 Major Associations
  • 18.2.8 Taxes Levied
  • 18.2.9 Investments
  • 18.2.10 Major Companies
• 18.3 Africa Eylea Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Eylea Market, Segmentation By Disorder, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.5 Africa Eylea Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 Regeneron Pharmaceuticals Inc
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 Bayer AG
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 Biocon Biologics Limited
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Samsung Bioepis Co. Ltd
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Financial Overview
• 19.6 Amgen Inc
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Business Strategy
  • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Sandoz Group AG Completed The Acquisition Of Cimerli, A Ranibizumab Biosimilar, From Coherus Biosciences
• 22.2 Astellas Pharma Inc Acquired IVERIC Bio Inc
• 22.3 Coherus BioSciences Inc Acquired Klinge Biopharma GmbH
• 22.4 AbbVie Inc Acquired Regenxbio Inc

23 Opportunities And Strategies

• 23.1 Global Eylea Market In 2028 - Countries Offering Most New Opportunities
• 23.2 Global Eylea Market In 2028 - Segments Offering Most New Opportunities
• 23.3 Global Eylea Market In 2028 - Growth Strategies
  • 23.3.1 Market Trend Based Strategies
  • 23.3.2 Competitor Strategies

24 Eylea Market, Conclusions And Recommendations

• 24.1 Conclusions
• 24.2 Recommendations
  • 24.2.1 Product
  • 24.2.2 Place
  • 24.2.3 Price
  • 24.2.4 Promotion
  • 24.2.5 People

25 Appendix

• 25.1 Geographies Covered
• 25.2 Market Data Sources
• 25.3 Research Methodology
• 25.4 Currencies
• 25.5 The Business Research Company
• 25.6 Copyright and Disclaimer